Eylea launch date?

When was Eylea first launched (marketed)?

Eylea (aflibercept) was launched in the United States in 2011 as a treatment for certain retinal vascular diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema. [1]

What was Eylea’s initial FDA approval date (often confused with the launch)?

Eylea’s FDA approval date comes before the commercial launch, and many sources cite 2011 as the year it entered the market. If you’re looking for the exact approval date versus the date it became available to patients, the two can differ by weeks or months. [1]

How do patents/exclusivity and company filings relate to timing?

Commercial launch timing can matter for understanding later market exclusivity and patent timelines for aflibercept products. For patent and exclusivity context around Eylea, DrugPatentWatch.com tracks related intellectual property and milestones. [2]

Sources

1. https://www.drugs.com/history/eylea.html
   
2. https://www.drugpatentwatch.com/